MDM2 and liposarcoma: However, differentiating benign from malignant adipocytic soft tissue tumors can be challenging, especially when faced with an atypical lipomatous tumor/well-differentiated liposarcoma, an intermediate entity that also possesses the MDM2 amplification and is locally aggressive.